Kisspeptin-10

Kisspeptin-10 is a peptide known for its role in stimulating the release of gonadotropin-releasing hormone, impacting reproductive health and potential regenerative medicine applications.

Not FDA Approved Emerging Research
Reviewed by Peptide Treatments Medical Advisory Board (Medical Advisory Board) 1 min read

Kisspeptin-10: At a Glance

Kisspeptin-10 stimulates the release of gonadotropin-releasing hormone (GnRH) from the hypothalamus, influencing reproductive hormone levels.

  • Enhances fertility and reproductive health
  • Potential role in regenerative medicine for hormone regulation
  • Possible local irritation at the injection site
Not FDA Approved Emerging Research

What is Kisspeptin-10?

Kisspeptin-10 is a naturally occurring peptide that plays a crucial role in the regulation of the reproductive system. It is a shorter form of kisspeptin, which is a key protein involved in initiating the release of gonadotropin-releasing hormone (GnRH) from the hypothalamus. This action is essential for the activation of the reproductive hormone cascade, which includes the secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) from the pituitary gland. These hormones are vital for normal reproductive function, influencing processes such as ovulation in females and testosterone production in males.

Mechanism of Action

Kisspeptin-10 operates by binding to the G-protein coupled receptor known as GPR54 (or KISS1R), located in the hypothalamus. This binding stimulates the secretion of GnRH, which then acts on the anterior pituitary gland to trigger the release of LH and FSH. These hormones are critical for the regulation of the menstrual cycle, fertility, and puberty. By modulating this hormonal pathway, Kisspeptin-10 has the potential to address various reproductive health issues.

Clinical Applications

Kisspeptin-10 has shown promise in several clinical applications, particularly in the field of reproductive health. It is being explored for its potential to treat conditions such as hypogonadotropic hypogonadism, a disorder characterized by low levels of reproductive hormones. Additionally, there is growing interest in its use for enhancing fertility treatments, as it may improve the chances of successful conception. Beyond reproductive health, researchers are investigating its role in regenerative medicine, where it may help in the regulation and balance of hormonal levels crucial for tissue repair and regeneration.

Safety & Side Effects

Kisspeptin-10 is generally considered safe when used under medical supervision. However, as with any therapeutic peptide, there may be side effects. The most commonly reported side effect is local irritation at the site of injection. It is important for patients to discuss any pre-existing conditions or medications with their healthcare provider to minimize the risk of adverse effects. Ongoing research continues to evaluate the long-term safety profile of Kisspeptin-10 in various clinical settings.

Related Conditions

References

  1. 1

    Kisspeptin system-physiology and clinical perspectives.

    Annales d'endocrinologie 2025 study
  2. 2

    The silent pandemic of stress: impact on menstrual cycle and ovulation.

    Stress (Amsterdam, Netherlands) 2025 study
  3. 3

    Menopause part I: Vasomotor symptoms (I).

    Taiwanese journal of obstetrics & gynecology 2025 study
  4. 4

    The Emerging Therapeutic Potential of Kisspeptin and Neurokinin B.

    Endocrine reviews 2024 study
  5. 5

    Sleep disturbance associated with the menopause.

    Menopause (New York, N.Y.) 2024 study
  6. 6

    Interactions between kisspeptin and bone: Cellular mechanisms, clinical evidence, and future potential.

    Annals of the New York Academy of Sciences 2024 study
  7. 7

    Jiawei Buzhong Yiqi Decoction attenuates polycystic ovary syndrome through regulating kisspeptin-GPR54-AKT-SHBG system.

    Phytomedicine : international journal of phytotherapy and phytopharmacology 2024 study
  8. 8

    Mechanism of elevated LH/FSH ratio in lean PCOS revisited: a path analysis.

    Scientific reports 2024 study
  9. 9

    Diagnostic and therapeutic use of oral micronized progesterone in endocrinology.

    Reviews in endocrine & metabolic disorders 2024 study
  10. 10

    Polycystic ovary syndrome: pathophysiology and therapeutic opportunities.

    BMJ medicine 2023 study

Next Step

Find a Kisspeptin-10 Provider

Search verified providers offering Kisspeptin-10 therapy. Compare credentials, read reviews, and book a consultation.